232 related articles for article (PubMed ID: 30010126)
1. TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
Sahoo A; Bejanin A; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Senjem ML; Machulda MM; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Whitwell JL; Josephs KA
J Alzheimers Dis; 2018; 64(4):1227-1233. PubMed ID: 30010126
[TBL] [Abstract][Full Text] [Related]
2. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
[TBL] [Abstract][Full Text] [Related]
4. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
5. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
6. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
[TBL] [Abstract][Full Text] [Related]
7. Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
Buciuc M; Wennberg AM; Weigand SD; Murray ME; Senjem ML; Spychalla AJ; Boeve BF; Knopman DS; Jack CR; Kantarci K; Parisi JE; Dickson DW; Petersen RC; Whitwell JL; Josephs KA
J Alzheimers Dis; 2020; 73(4):1511-1523. PubMed ID: 31929165
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
[TBL] [Abstract][Full Text] [Related]
9. Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.
Gefen T; Gasho K; Rademaker A; Lalehzari M; Weintraub S; Rogalski E; Wieneke C; Bigio E; Geula C; Mesulam MM
Brain; 2012 May; 135(Pt 5):1554-65. PubMed ID: 22522938
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT
Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152
[TBL] [Abstract][Full Text] [Related]
11. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
[TBL] [Abstract][Full Text] [Related]
12. Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss.
Carlos AF; Koga S; Graff-Radford NR; Baker MC; Rademakers R; Ross OA; Dickson DW; Josephs KA
Neuropathology; 2024 Apr; 44(2):115-125. PubMed ID: 37525358
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.
Bigio EH; Mishra M; Hatanpaa KJ; White CL; Johnson N; Rademaker A; Weitner BB; Deng HX; Dubner SD; Weintraub S; Mesulam M
Acta Neuropathol; 2010 Jul; 120(1):43-54. PubMed ID: 20361198
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
Carlos AF; Machulda MM; Rutledge MH; Nguyen AT; Reichard RR; Baker MC; Rademakers R; Dickson DW; Petersen RC; Josephs KA
J Alzheimers Dis; 2023; 93(4):1521-1535. PubMed ID: 37182869
[TBL] [Abstract][Full Text] [Related]
15. Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes.
Tomé SO; Vandenberghe R; Ospitalieri S; Van Schoor E; Tousseyn T; Otto M; von Arnim CAF; Thal DR
Acta Neuropathol Commun; 2020 Apr; 8(1):61. PubMed ID: 32349792
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 is a key player in the clinical features associated with Alzheimer's disease.
Josephs KA; Whitwell JL; Weigand SD; Murray ME; Tosakulwong N; Liesinger AM; Petrucelli L; Senjem ML; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Jack CR; Parisi JE; Petersen RC; Dickson DW
Acta Neuropathol; 2014; 127(6):811-24. PubMed ID: 24659241
[TBL] [Abstract][Full Text] [Related]
17. Distinct Patterns of Hippocampal Pathology in Alzheimer's Disease with Transactive Response DNA-binding Protein 43.
Minogue G; Kawles A; Zouridakis A; Keszycki R; Macomber A; Lubbat V; Gill N; Mao Q; Flanagan ME; Zhang H; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
Ann Neurol; 2023 Dec; 94(6):1036-1047. PubMed ID: 37592884
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
[TBL] [Abstract][Full Text] [Related]
19. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
Teipel S; Grothe MJ;
Neurobiol Dis; 2023 May; 180():106070. PubMed ID: 36898615
[TBL] [Abstract][Full Text] [Related]
20. Differential clinicopathologic and genetic features of late-onset amnestic dementias.
Murray ME; Cannon A; Graff-Radford NR; Liesinger AM; Rutherford NJ; Ross OA; Duara R; Carrasquillo MM; Rademakers R; Dickson DW
Acta Neuropathol; 2014 Sep; 128(3):411-21. PubMed ID: 24899141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
